pre-ipo
Stage
About
Sutro Biopharma is a clinical-stage biotechnology company developing next-generation antibody-drug conjugate therapeutics for cancer treatment using proprietary technology to deliver single- and dual-payload ADCs.
Explore Sutro Biopharma, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.